← Back

Dahu Aquaculture Co Ltd

Dahu Health Industry Co., Ltd., together with its subsidiaries, operates in aquatic products, wine and spirits, healthcare, and other businesses primarily in China. It offers chilled and frozen aquatic products, wine, pearl jewelry, and health products. The company also provides patient care, rehabilitation, and nursing services, including neurological, bone and joint, geriatric, cardiopulmonary, pediatric rehabilitation, basic living care, and end-of-life care. Formerly known as Dahu Aquaculture Co., Ltd., it changed its name to Dahu Health Industry Co., Ltd. in October 2025. Founded in 1999, it is based in Changde, China.

Country
Price · split & dividend adjusted
News & notes moving 600257.CG
600257.CG3

Dahu Co. reports first-half 2026 net profit of 16.88 million yuan, turning from loss to profit year-on-year

Dahu Co. released its 2026 interim report, with net profit attributable to the parent company of 16.88 million yuan, an increase of 19.45 million yuan compared with the same period last year, achieving a turnaround from loss to profit. The company's total operating revenue was 434 million yuan, up 1.98 percent year-on-year; net cash inflow from operating activities was 56.01 million yuan, down 33.49 percent year-on-year. The company's latest asset-liability ratio was 46.37 percent, gross margin was 29.43 percent, return on equity was 2.07 percent, and diluted earnings per share was 0.04 yuan.
Jiemian·36dRead more →
600257.CG

National cigarette and alcohol retail sales rose 13.2% year-on-year in the first half; baijiu sector rallies but earnings generally expected to decline

Data released by the National Bureau of Statistics on July 15 showed that in the first half of the year, the absolute retail sales of cigarette and alcohol products nationwide reached 354.7 billion yuan, up 13.2 percent year-on-year. In June alone, the absolute figure was 53.7 billion yuan, up 12.1 percent year-on-year. Boosted by this news, the A-share baijiu sector rose across the board that day. Gujing Gongjiu, Jinzhongzi Liquor, and Dahu Aquaculture hit the daily limit up. Luzhou Laojiao, Shanxi Xinghuacun Fenjiu, Shunxin Agriculture, and Jinshiyuan gained more than 5 percent. The sector's overall index rose 3.06 percent. However, the industry remains in a period of deep adjustment. As of July 15, about eight A-share listed baijiu companies had disclosed their first-half earnings forecasts. Except for Wuliangye, which is expected to report growth, the rest generally saw profit declines or losses. Tianyoude Liquor's net profit fell 76 to 84 percent year-on-year. Shunxin Agriculture's net profit fell 69.34 to 79.18 percent year-on-year. Jinzhongzi Liquor, Huangtai Liquor, Shuijingfang, and ST Spring are expected to report losses. Proactive destocking has become a common choice for liquor companies. Shuijingfang's channel inventory fell about 50 percent year-on-year. Shede Spirits controlled shipments to stabilize prices. Jiugui Liquor raised the strategic price of its 52-degree 500ml Neican liquor by 30 yuan per bottle and suspended shipments until August 15. Xiao Zhuqing, a Chinese liquor industry analyst, said consumers are shifting to affordable daily-drinking liquors priced under 100 yuan, and the premium on high-end famous brands is shrinking. Liquor companies need to face consumers directly to digest inventory.
证券时报·66dRead more →
600257.CG

Dahu Shares Expects to Turn Profitable in First Half of 2026 with Net Profit of 15 Million to 20 Million Yuan

Dahu Shares disclosed an earnings forecast, expecting to achieve a net profit attributable to shareholders of 15 million to 20 million yuan in the first half of 2026, compared with a loss of 2.57 million yuan in the same period last year, turning losses into profits year-on-year. Deducted non-recurring net profit is expected to be 9 million to 13 million yuan, compared with a loss of 4.54 million yuan in the same period last year. The company stated that the significant improvement in performance was mainly due to the steady increase in inpatient admissions and the continuous expansion of the inpatient business scale in the rehabilitation medical business. At the same time, through refined cost control across the entire process, costs were effectively reduced. Driven by both business growth and cost savings, the operating profit of the rehabilitation medical business increased significantly year-on-year.
中国证券报·67dRead more →